1. Altevogt, P., Leidig, S., and Heckl-Oestreicher, B., 1984, Resistance of metastatic tumor variants to tumor-specific cytoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells.Cancer Research, 44, 5305?5313.
2. Baker, R. M., Brunette, D. M., Mankovitz, R., Thompson, L. H., Whitmore, G. F., Siminovitch, L., and Till, J. E., 1974, Ouabain-resistant mutants of mouse and hamster cells in culture.Cell, 1, 9?21.
3. Baniyash, M., Netanel, T., and Witz, I. P., 1981, Differences in cell density associated with differences in lung-colonizing ability of B16 melanoma cells.Cancer Research, 41, 433?437.
4. Barsky, S. H., Rao, C. N., Williams, J. E., and Liotta, L. A., 1984, Laminin molecular domains which alter metastasis in a murine model.Journal of Clinical Investigation, 74, 843?848.
5. Baserga, R., Putong, P. B., Tyler, S., and Wartman, W. B., 1960, The dose-response relationship between the number of embolic tumor cells and the incidence of bloodborne metastases.British Journal of Cancer, 14, 173?185.